{
     "PMID": "26212551",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160209",
     "LR": "20170801",
     "IS": "1873-2968 (Electronic) 0006-2952 (Linking)",
     "VI": "97",
     "IP": "4",
     "DP": "2015 Oct 15",
     "TI": "Alpha7 nicotinic receptor activation protects against oxidative stress via heme-oxygenase I induction.",
     "PG": "473-481",
     "LID": "S0006-2952(15)00392-5 [pii] 10.1016/j.bcp.2015.07.022 [doi]",
     "AB": "Subchronic oxidative stress and inflammation are being increasingly implicated in the pathogenesis of numerous diseases, such as Alzheimer's or Parkinson's disease. This study was designed to evaluate the potential protective role of alpha7 nicotinic receptor activation in an in vitro model of neurodegeneration based on subchronic oxidative stress. Rat organotypic hippocampal cultures (OHCs) were exposed for 4 days to low concentration of lipopolysaccharide (LPS) and the complex III mitochondrial blocker, antimycin-A. Antimycin-A (0.1muM) and lipopolysaccharide (1ng/ml) caused low neurotoxicity on their own, measured as propidium iodide fluorescence in CA1 and CA3 regions. However, their combination (LPS/AA) caused a greater detrimental effect, in addition to mitochondrial depolarization, overproduction of reactive oxygen species (ROS) and Nox4 overexpression. Antimycin-A per se increased ROS and mitochondrial depolarization, although these effects were significantly higher when combined with LPS. More interesting was the finding that exposure of OHCs to the combination of LPS/AA triggered aberrant protein aggregation, measured as thioflavin S immunofluorescence. The alpha7 nicotinic receptor agonist, PNU282987, prevented the neurotoxicity and the pathological hallmarks observed in the LPS/AA subchronic toxicity model (oxidative stress and protein aggregates); these effects were blocked by alpha-bungarotoxin and tin protoporphyrin, indicating the participation of alpha7 nAChRs and heme-oxygenase I induction. In conclusion, subchronic exposure of OHCs to low concentration of antimycin-A plus LPS reproduced pathological features of neurodegenerative disorders. alpha7 nAChR activation ameliorated these alterations by a mechanism involving heme-oxygenase I induction.",
     "CI": [
          "Copyright (c) 2015 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Navarro, Elisa",
          "Buendia, Izaskun",
          "Parada, Esther",
          "Leon, Rafael",
          "Jansen-Duerr, Pidder",
          "Pircher, Haymo",
          "Egea, Javier",
          "Lopez, Manuela G"
     ],
     "AU": [
          "Navarro E",
          "Buendia I",
          "Parada E",
          "Leon R",
          "Jansen-Duerr P",
          "Pircher H",
          "Egea J",
          "Lopez MG"
     ],
     "AD": "Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Instituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain. Institute for Biomedical Aging Research, Universitat Innsbruck, Innsbruck, Austria. Institute for Biomedical Aging Research, Universitat Innsbruck, Innsbruck, Austria. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Instituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain. Instituto Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Spain; Instituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain. Electronic address: manuela.garcia@uam.es.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150723",
     "PL": "England",
     "TA": "Biochem Pharmacol",
     "JT": "Biochemical pharmacology",
     "JID": "0101032",
     "RN": [
          "0 (Benzamides)",
          "0 (Bridged Bicyclo Compounds)",
          "0 (Lipopolysaccharides)",
          "0 (Nicotinic Agonists)",
          "0 (PNU-282987)",
          "0 (Reactive Oxygen Species)",
          "0 (alpha7 Nicotinic Acetylcholine Receptor)",
          "642-15-9 (Antimycin A)",
          "EC 1.14.14.18 (Heme Oxygenase (Decyclizing))",
          "EC 1.14.14.18 (Hmox1 protein, rat)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antimycin A/administration & dosage/pharmacology",
          "Benzamides/pharmacology",
          "Bridged Bicyclo Compounds/pharmacology",
          "Cell Death/drug effects",
          "Cells, Cultured",
          "Enzyme Induction/*drug effects/physiology",
          "Heme Oxygenase (Decyclizing)/genetics/*metabolism",
          "Hippocampus/*cytology",
          "Lipopolysaccharides",
          "Mitochondria/drug effects/metabolism",
          "Nicotinic Agonists/administration & dosage/pharmacology",
          "Oxidative Stress/*physiology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Reactive Oxygen Species/metabolism",
          "alpha7 Nicotinic Acetylcholine Receptor/agonists/*metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Heme-oxygenase I",
          "Neuroprotection",
          "Organotypic cultures",
          "Oxidative stress",
          "Protein aggregation",
          "alpha7 nicotinic receptor"
     ],
     "EDAT": "2015/07/28 06:00",
     "MHDA": "2016/02/10 06:00",
     "CRDT": [
          "2015/07/28 06:00"
     ],
     "PHST": [
          "2015/05/29 00:00 [received]",
          "2015/07/17 00:00 [accepted]",
          "2015/07/28 06:00 [entrez]",
          "2015/07/28 06:00 [pubmed]",
          "2016/02/10 06:00 [medline]"
     ],
     "AID": [
          "S0006-2952(15)00392-5 [pii]",
          "10.1016/j.bcp.2015.07.022 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Biochem Pharmacol. 2015 Oct 15;97(4):473-481. doi: 10.1016/j.bcp.2015.07.022. Epub 2015 Jul 23.",
     "term": "hippocampus"
}